Reuters

India's Dr Lal Path Labs posts higher Q3 profit on steady testing demand

Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...
CNBCTV18

Dr Lal PathLabs establishes UAE subsidiary to pursue diagnostics opportunities

Dr Lal PathLabs has incorporated a wholly owned subsidiary, DR LAL PATHLABS FZCO, in Dubai, United Arab Emirates. The ...
MSN on MSN

Dr Lal PathLabs share price in focus: Emkay bullish on BSE 500 company; maintains buy call - 5 reasons why

Dr Lal PathLabs share price in focus: The BSE 500 company announced its Q4 earnings for the financial year 2025-26 on April ...
Reuters

India's Dr Lal Path Labs beats quarterly profit view on medical testing boom

April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...
health.economictimes.indiatimes

Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong

Bengaluru: Dr. Lal Path Labs reported a ‍lower third-quarter profit on Friday after taking a one-time charge ⁠linked to India's new labour code, despite strong demand for its bundled test packages.